Why rejecting the standard vitamin K shot for newborns is causing dangerous, sometimes fatal, bleeding. Understand the vital facts behind this simple injection.
Encoded Therapeutics doses the first patient in the pivotal ENDEAVOR Part 2 study for ETX101, a gene therapy for Dravet syndrome. Major progress reported.
New data from Digestive Disease Week 2026 reveals once-daily NIM-1324 for IBD offers a superior efficacy profile. See the future of ulcerative colitis and Crohn’s treatment.
Misinformation about sunscreen puts 16M Americans at higher skin cancer risk, especially Gen Z. Get the facts on sun safety.
Hypochlorous acid skincare, an FDA-cleared ‘magic molecule,’ is now at 6,000 CVS stores. This expansion makes gentle, effective treatment more accessible than ever.
Emergent partners to manufacture Japanese Encephalitis vaccine in the US, securing exclusive distribution to the government after FDA approval. A major biosecurity move.
A nurse accused of misgendering a patient faced backlash, now cleared. Our analysis explores consequences, free speech, and healthcare rules.
Ardelyx to present new data on IBS-C treatment patterns and healthcare costs at Digestive Disease Week 2026. See how patient characteristics drive decisions.
XiFin debuts its new AI Appeals agent for revenue cycle management at Executive War College. See how it tackles healthcare reimbursement complexity.
